Annual Current Ratio
4.32
-1.86-30.10%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual current ratio is 4.32, with the most recent change of -1.86 (-30.10%) on December 31, 2023.
- During the last 3 years, CMMB annual current ratio has fallen by -4.68 (-52.00%).
- CMMB annual current ratio is now -81.74% below its all-time high of 23.66, reached on December 31, 2021.
Performance
CMMB Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
4.57
+1.45+46.47%
September 1, 2024
Summary
- As of February 8, 2025, CMMB quarterly current ratio is 4.57, with the most recent change of +1.45 (+46.47%) on September 1, 2024.
- Over the past year, CMMB quarterly current ratio has increased by +1.45 (+46.47%).
- CMMB quarterly current ratio is now -88.69% below its all-time high of 40.39, reached on September 30, 2021.
Performance
CMMB Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
CMMB Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.1% | +46.5% |
| 3 y3 years | -52.0% | +46.5% |
| 5 y5 years | -52.0% | +46.5% |
CMMB Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.7% | at low | -80.7% | +46.5% |
| 5 y | 5-year | -81.7% | at low | -88.7% | +46.5% |
| alltime | all time | -81.7% | at low | -88.7% | +46.5% |
Chemomab Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 4.57(+46.5%) |
| Jun 2024 | - | 3.12(-18.5%) |
| Mar 2024 | - | 3.83(-11.3%) |
| Dec 2023 | 4.32(-30.1%) | 4.32(+6.4%) |
| Jun 2023 | - | 4.06(-15.9%) |
| Mar 2023 | - | 4.83(-21.8%) |
| Dec 2022 | 6.18 | 6.18(-30.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 8.90(-28.7%) |
| Jun 2022 | - | 12.48(-26.0%) |
| Mar 2022 | - | 16.87(-28.7%) |
| Dec 2021 | 23.66(+162.9%) | 23.66(-41.4%) |
| Sep 2021 | - | 40.39(+26.7%) |
| Jun 2021 | - | 31.88(+148.1%) |
| Mar 2021 | - | 12.85(+42.8%) |
| Dec 2020 | 9.00 | 9.00 |
FAQ
- What is Chemomab Therapeutics annual current ratio?
- What is the all time high annual current ratio for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual current ratio year-on-year change?
- What is Chemomab Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly current ratio year-on-year change?
What is Chemomab Therapeutics annual current ratio?
The current annual current ratio of CMMB is 4.32
What is the all time high annual current ratio for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual current ratio is 23.66
What is Chemomab Therapeutics annual current ratio year-on-year change?
Over the past year, CMMB annual current ratio has changed by -1.86 (-30.10%)
What is Chemomab Therapeutics quarterly current ratio?
The current quarterly current ratio of CMMB is 4.57
What is the all time high quarterly current ratio for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly current ratio is 40.39
What is Chemomab Therapeutics quarterly current ratio year-on-year change?
Over the past year, CMMB quarterly current ratio has changed by +1.45 (+46.47%)